Internal Medicine · Charlotte, NC
NPI
1841269925
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7108 Pineville Matthews Rd, Suite 102
Charlotte, NC, 28226
Phone (704) 542-2191
Groups this clinician bills Medicare through
Medicare paid, 2024
$119K
2,666 services
Medicare patients, 2024
105
Average age 73
Drug cost, 2024
$701K
5,434 prescriptions
Company payments, 2025
$1,270
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Avinash D Shah was code 99490 (chronic, principal, and transitional care management), 401 times for 72 patients. In total Avinash D Shah billed 2,666 services in 75 codes, and Medicare paid $119K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 401 | 72 | $42.78 | $17K |
| 99214 Office E&M - Established | Office | 315 | 86 | $81.48 | $26K |
| 99457 E&M - Miscellaneous | Office | 238 | 41 | $32.56 | $7,748 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 221 | 60 | $35.05 | $7,746 |
| 99454 E&M - Miscellaneous | Office | 127 | 23 | $32.43 | $4,119 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 120 | 12 | $0.75 | $89.41 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 66 | 17 | $53.52 | $3,533 |
| 99215 Office E&M - Established | Office | 59 | 34 | $111.09 | $6,554 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 52 | 52 | $121.30 | $6,307 |
| 99497 Care Management/Coordination | Office | 49 | 49 | $50.22 | $2,461 |
| 71046 X-ray - Chest | Office | 40 | 37 | $23.43 | $937 |
| 81002 Clinical Chemistry | Office | 39 | 32 | $3.32 | $130 |
| 93000 Electrocardiogram | Office | 37 | 34 | $9.67 | $358 |
| 99458 E&M - Miscellaneous | Office | 32 | 13 | $29.09 | $931 |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 31 | 19 | $96.58 | $2,994 |
By year: 2022 $107K for 1,919 services; 2023 $138K for 3,059 services; 2024 $119K for 2,666 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 39 | 32 | $3.32 | $130 |
| 82274 Immunoassay | 14 | 14 | $14.71 | $206 |
Medicare prescription drug claims, 2024
In 2024, the drug Avinash D Shah prescribed most often to Medicare patients was Atorvastatin Calcium, with 281 prescriptions and refills. In total Avinash D Shah wrote 5,434 Medicare prescriptions that cost $701K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 281 | 820 | 85 | $2,259 |
| Amlodipine Besylate Generic | 265 | 735 | 75 | $1,108 |
| Levothyroxine Sodium Generic | 189 | 554 | 52 | $1,312 |
| Omeprazole Generic | 170 | 450 | 52 | $1,976 |
| Rosuvastatin Calcium Generic | 149 | 397 | 40 | $2,111 |
| Metoprolol Succinate Generic | 135 | 371 | 38 | $1,304 |
| Meloxicam Generic | 133 | 250 | 38 | $613 |
| Alendronate Sodium Generic | 121 | 320 | 38 | $417 |
| Lisinopril Generic | 117 | 336 | 31 | $672 |
| Losartan Potassium Generic | 110 | 294 | 29 | $760 |
| Metformin Hcl Generic | 108 | 256 | 29 | $726 |
| Tamsulosin Hcl Generic | 98 | 277 | 30 | $1,556 |
| Metoprolol Tartrate Generic | 92 | 249 | 22 | $732 |
| Jardiance Empagliflozin | 92 | 195 | 23 | $117K |
| Oxycodone Hcl Generic | 82 | 82 | 14 | $1,602 |
Brand drugs: 653 claims; generic drugs: 4,749 claims; opioid claims: 222.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Avinash D Shah $1,270 ($1,270 in general payments such as food, travel and fees) from 12 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $271.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 15 | $271 |
| Novo Nordisk Inc NVO | 13 | $240 |
| Lilly USA, LLC LLY | 8 | $166 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $163 |
| Abbvie Inc. ABBV | 6 | $137 |
| Antares Pharma, Inc. | 1 | $71.71 |
| Pfizer Inc. PFE | 3 | $67.51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $48.57 |
| Seqirus USA Inc CSL.AX | 2 | $41.88 |
| Abbott Laboratories ABT | 1 | $24.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.